Back to U.S. Bancorp U.S. Bancorp

LLYLLY

Showing 9 of 31 quarters

Position history for U.S. BancorpU.S. Bancorp's holdings in Eli Lilly and Company

Yes. U.S. Bancorp holds 1,345,324 shares of LLY (Eli Lilly), worth $1.6B, as of its Q3 2026 13F filing. It reduced the position by 9,399 shares (-0.7%) from Q2 2026. U.S. Bancorp has held LLY in every 13F on record since Q1 2019, 31 quarterly filings. LLY is 1.7% of U.S. Bancorp's reported 13F portfolio.

Current Value

$1.6B

Current Shares

1.3M

Total Value Change

-$377M

Total Shares Change

-837,245

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
1.3M
-0.7%
$1.6B1.7%$1,157.08
0
2026-Q2
Decreased
1.4M
-0.2%
$1.6B1.8%$1,197.71
0
2026-Q1
Decreased
1.4M
-0.9%
$1.2B1.5%$916.88
0
2025-Q4
Decreased
1.4M
-0.3%
$1.5B1.7%$1,069.51
0
2025-Q3
Increased
1.4M
+0.1%
$1B1.2%$758.22
50
2025-Q2
Decreased
1.4M
-4.3%
$1.1B1.3%$772.95
0
2025-Q1
Decreased
1.4M
-31.5%
$1.2B1.6%$817.26
0
2024-Q4
Decreased
2.1M
-4.1%
$1.6B2.1%$762.60
0
2024-Q3
Increased
2.2M
+1.2%
$1.9B2.5%$873.71
55

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used